.SILAHKAN MENGGUNAKAN " MESIN TRANSLATE "..GOOGLE TRANSLATE
DISAMPING KANAN INI.............
PLEASE USE ........ "TRANSLATE MACHINE" .. GOOGLE TRANSLATE BESIDE RIGHT THIS
.....................................
DISAMPING KANAN INI.............
PLEASE USE ........ "TRANSLATE MACHINE" .. GOOGLE TRANSLATE BESIDE RIGHT THIS
.....................................
Fragmen
novel protein dapat melindungi terhadap penyakit Alzheimer's
Novel protein fragments may protect against Alzheimer's
Date:
May 13, 2014
Source:
American Friends of Tel Aviv
University
Summary:
Alzheimer's research has centered on trying to
understand the protective or regenerative properties of brain cells as an avenue
for treating the widespread disease. Now a researcher has discovered novel
protein fragments that have proven protective properties for cognitive
functioning. Her findings have the potential to serve as a pipeline for new
drug candidates to treat the disease.
...............................
The devastating loss of memory and consciousness in
Alzheimer's disease is caused by plaque accumulations and tangles in neurons,
which kill brain cells. Alzheimer's research has centered on trying to
understand the pathology as well as the potential protective or regenerative
properties of brain cells as an avenue for treating the widespread disease.
Now Prof.
Illana Gozes, the incumbent of the Lily and Avraham Gildor Chair for the
Investigation of Growth Factors and director of the Adams Super Center for
Brain Studies at the Sackler Faculty of Medicine and a member of Tel Aviv
University's Sagol School of Neuroscience, has discovered novel protein
fragments that have proven protective properties for cognitive functioning.
In a study
published in the Journal of Alzheimer's Disease, Prof. Gozes examined
the protective effects of two newly discovered protein fragments in mice
afflicted with Alzheimer's disease-like symptoms. Her findings have the
potential to serve as a pipeline for new drug candidates to treat the disease.
NAP time for
Alzheimer's
"Several
years ago we discovered that NAP, a snippet of a protein essential for brain
formation, which later showed efficacy in Phase 2 clinical trials in mild
cognitive impairment patients, a precursor to Alzheimer's," said Prof.
Gozes. "Now, we're investigating whether there are other novel NAP-like
sequences in other proteins. This is the question that led us to our
discovery."
Prof. Gozes'
research focused on the microtubule network, a crucial part of cells in our
bodies. Microtubules act as a transportation system within nerve cells,
carrying essential proteins and enabling cell-to-cell communications. But in
neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's, this network
breaks down, hindering motor abilities and cognitive function.
"NAP
operates through the stabilization of microtubules -- tubes within the cell
which maintain cellular shape. They serve as 'train tracks' for movement of
biological material," said Prof. Gozes. "This is very important to
nerve cells, because they have long processes and would otherwise collapse. In
Alzheimer's disease, these microtubules break down. The newly discovered
protein fragments, just like NAP before them, work to protect microtubules,
thereby protecting the cell."
Down the
tubes
In her new
study, Prof. Gozes and her team looked at the subunit of the microtubule -- the
tubulin -- and the protein TAU (tubulin-associated unit), important for
assembly and maintenance of the microtubule. Abnormal TAU proteins form the
tangles that contribute to Alzheimer's; increased tangle accumulation is
indicative of cognitive deterioration. Prof. Gozes decided to test both the
tubulin and the TAU proteins for NAP-like sequences. After confirming NAP-like
sequences in both tubulin subunits and in TAU, she tested the fragments in
tissue cultures for nerve-cell protecting properties against amyloid peptides,
the cause of plaque build up in Alzheimer patients' brains.
"From
the tissue culture, we moved to a 10-month-old transgenic mouse model with
frontotemporal dementia-like characteristics, which exhibits TAU pathology and
cognitive decline," said Prof. Gozes. "We tested one compound -- a
tubulin fragment -- and saw that it protected against cognitive deficits. When
we looked at the 'dementia'-afflicted brain, there was a reduction in the NAP
parent protein, but upon treatment with the tubulin fragment, the protein was
restored to normal levels."
Prof. Gozes
and her team also measured the brain-to-body mass ratio, an indicator of brain
degeneration, and saw a significant decrease in the mouse model compared to
normal mice. Following the introduction of the tubulin fragments, however, the
mouse's brain to body ratio returned to normal. "We clearly see here the
protective effect of the treatment," said Prof. Gozes. "We witnessed
the restorative and protective effects of totally new protein fragments,
derived from proteins critical to cell function, in tissue cultures and on
animal models."
Story
Source:
The above
story is based on materials provided by American Friends of Tel Aviv University. Note:
Materials may be edited for content and length.
Journal
Reference:
- Illana Gozes et al. Novel Tubulin and Tau Neuroprotective Fragments Sharing Structural Similarities with the Drug Candidate NAP (Davuentide). Journal of Alzheimer's Disease, May 2014 DOI: 10.3233/JAD-131664
Cite This
Page:
American Friends of Tel Aviv
University. "Novel protein fragments may protect against
Alzheimer's." ScienceDaily. ScienceDaily, 13 May 2014.
<www.sciencedaily.com/releases/2014/05/140513152955.htm>.